160 related articles for article (PubMed ID: 25176123)
1. Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery.
Mead AN
Expert Opin Drug Discov; 2014 Nov; 9(11):1281-91. PubMed ID: 25176123
[TBL] [Abstract][Full Text] [Related]
2. How good are current approaches to nonclinical evaluation of abuse and dependence?
Moser P; Wolinsky T; Duxon M; Porsolt RD
J Pharmacol Exp Ther; 2011 Mar; 336(3):588-95. PubMed ID: 21098089
[TBL] [Abstract][Full Text] [Related]
3. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
[TBL] [Abstract][Full Text] [Related]
4. Current approaches and issues in non-clinical evaluation of abuse and dependence.
Moser P; Wolinsky T; Castagné V; Duxon M
J Pharmacol Toxicol Methods; 2011; 63(2):160-7. PubMed ID: 20868759
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the vulnerability to drug abuse: a review of preclinical studies.
Roth ME; Cosgrove KP; Carroll ME
Neurosci Biobehav Rev; 2004 Oct; 28(6):533-46. PubMed ID: 15527861
[TBL] [Abstract][Full Text] [Related]
6. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview.
Sanchis-Segura C; Spanagel R
Addict Biol; 2006 Mar; 11(1):2-38. PubMed ID: 16759333
[TBL] [Abstract][Full Text] [Related]
7. Abstinence-Conflict Model: Toward an Optimal Animal Model for Screening Medications Promoting Drug Abstinence.
Peck JA
Int Rev Neurobiol; 2016; 126():391-402. PubMed ID: 27055619
[TBL] [Abstract][Full Text] [Related]
8. Mouse model of relapse to the abuse of drugs: procedural considerations and characterizations.
Yan Y; Nabeshima T
Behav Brain Res; 2009 Jan; 196(1):1-10. PubMed ID: 18782591
[TBL] [Abstract][Full Text] [Related]
9. Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse.
Swedberg MD
J Pharmacol Toxicol Methods; 2016; 81():295-305. PubMed ID: 27235786
[TBL] [Abstract][Full Text] [Related]
10. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.
Zernig G; Ahmed SH; Cardinal RN; Morgan D; Acquas E; Foltin RW; Vezina P; Negus SS; Crespo JA; Stöckl P; Grubinger P; Madlung E; Haring C; Kurz M; Saria A
Pharmacology; 2007; 80(2-3):65-119. PubMed ID: 17570954
[TBL] [Abstract][Full Text] [Related]
11. Breaking the loop: oxytocin as a potential treatment for drug addiction.
McGregor IS; Bowen MT
Horm Behav; 2012 Mar; 61(3):331-9. PubMed ID: 22198308
[TBL] [Abstract][Full Text] [Related]
12. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
Genung V
Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Abuse Potential Assessment.
Kallman MJ
Handb Exp Pharmacol; 2015; 229():115-30. PubMed ID: 26091638
[TBL] [Abstract][Full Text] [Related]
14. From bedside to bench and back again: a 30-year saga.
Gold MS
Physiol Behav; 2011 Jul; 104(1):157-61. PubMed ID: 21530563
[TBL] [Abstract][Full Text] [Related]
15. Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory.
Carroll ME; Anker JJ; Perry JL
Drug Alcohol Depend; 2009 Oct; 104 Suppl 1():S70-8. PubMed ID: 19136222
[TBL] [Abstract][Full Text] [Related]
16. Measuring the reinforcing strength of abused drugs.
Bergman J; Paronis CA
Mol Interv; 2006 Oct; 6(5):273-83. PubMed ID: 17035668
[TBL] [Abstract][Full Text] [Related]
17. Reward and abuse of opiates.
Ramsey NF; Van Ree JM
Pharmacol Toxicol; 1992 Aug; 71(2):81-94. PubMed ID: 1438034
[TBL] [Abstract][Full Text] [Related]
18. How does stress increase risk of drug abuse and relapse?
Sinha R
Psychopharmacology (Berl); 2001 Dec; 158(4):343-59. PubMed ID: 11797055
[TBL] [Abstract][Full Text] [Related]
19. A pharmacological classification of drugs of abuse.
Nahas GG
Bull Narc; 1981; 33(2):1-19. PubMed ID: 6272921
[TBL] [Abstract][Full Text] [Related]
20. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Niwa M; Yan Y; Nabeshima T
Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
